These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 8150842

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. The use of recombinant human erythropoietin and cultured epithelial autografts in a Jehovah's Witness with a major thermal injury.
    Moghtader JC, Edlich RF, Mintz PD, Zachmann GC, Himel HN.
    Burns; 1994 Apr; 20(2):176-7. PubMed ID: 8198726
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Management of severe anemia without transfusion in a pediatric Jehovah's Witness patient.
    Akingbola OA, Custer JR, Bunchman TE, Sedman AB.
    Crit Care Med; 1994 Mar; 22(3):524-8. PubMed ID: 8125005
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Treatment of perioperative acute anemia by human recombinant erythropoietin in a Jehovah's witness].
    Boursas M, Benhassine L, Paris F, Kempf J, Vuillemin F.
    Ann Fr Anesth Reanim; 1997 Mar; 16(3):312-3. PubMed ID: 9732784
    [No Abstract] [Full Text] [Related]

  • 10. Reducing postburn injury anemia in a Jehovah's Witness patient.
    Barsun A, Sen S, Palmieri TL, Greenhalgh DG.
    J Burn Care Res; 2014 Mar; 35(4):e258-61. PubMed ID: 24121804
    [Abstract] [Full Text] [Related]

  • 11. Use of recombinant human erythropoietin to avoid blood transfusion in a Jehovah's Witness requiring hemispherectomy. Case report.
    Schiff SJ, Weinstein SL.
    J Neurosurg; 1993 Oct; 79(4):600-2. PubMed ID: 8410232
    [Abstract] [Full Text] [Related]

  • 12. Erythropoietin use in a Jehovah's Witness patient.
    Walton T, Macon EJ.
    Ann Pharmacother; 2002 Apr; 36(4):729-30. PubMed ID: 11936087
    [No Abstract] [Full Text] [Related]

  • 13. Recombinant human erythropoietin in severe anaemia: issues of dosing and duration.
    Charles A, Purtill M, Napolitano LM.
    Anaesth Intensive Care; 2006 Dec; 34(6):793-6. PubMed ID: 17183900
    [Abstract] [Full Text] [Related]

  • 14. The use of recombinant human erythropoietin in a Jehovah's Witness requiring major reconstructive surgery.
    Connor JP, Olsson CA.
    J Urol; 1992 Jan; 147(1):131-2. PubMed ID: 1729504
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Use of 2-chlorodeoxyadenosine, granulocyte-colony-stimulating factor, and erythropoietin in a Jehovah's Witness with hairy cell leukemia.
    Couban S, Wilson WE.
    Am J Hematol; 1995 Jul; 49(3):255-6. PubMed ID: 7541605
    [No Abstract] [Full Text] [Related]

  • 20. Case study. Erythropoietin for anaemia in a preterm Jehovah's Witness baby.
    Davis P, Herbert M, Davies DP, Verrier Jones ER.
    Early Hum Dev; 1992 Jul; 28(3):279-83. PubMed ID: 1592011
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.